Stay updated with breaking news from Nasdaq Gh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the sixteen research firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12-month […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12-month price target […]
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1-year […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 6,340,000 shares, a drop of 9.4% from the October 31st total of 7,000,000 shares. Based on an average trading volume of 1,800,000 shares, the days-to-cover ratio […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) insider Kumud Kalia sold 5,800 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $26.37, for a total value of $152,946.00. Following the completion of the transaction, the insider now directly owns 5,926 […]